Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy

Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resistant depression (TRD), administered intravenously withou...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychoactive drugs Vol. 51; no. 2; pp. 189 - 198
Main Authors: Dore, Jennifer, Turnipseed, Brent, Dwyer, Shannon, Turnipseed, Andrea, Andries, Julane, Ascani, German, Monnette, Celeste, Huidekoper, Angela, Strauss, Nicole, Wolfson, Phil
Format: Journal Article
Language:English
Published: United States Taylor & Francis 01-04-2019
Haight Ashbury Publications
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resistant depression (TRD), administered intravenously without a psychotherapeutic component. In these settings, ketamine's psychedelic effects are viewed as undesirable "side effects." In contrast, we believe ketamine can benefit patients with a wide variety of diagnoses when administered with psychotherapy and using its psychedelic properties without need for intravenous (IV) access. Its proven safety over decades of use makes it ideal for office and supervised at-home use. The unique experience that ketamine facilitates with its biological, experiential, and psychological impacts has been tailored to optimize office-based treatment evolving into a method that we call Ketamine Assisted Psychotherapy (KAP). This article is the first to explore KAP within an analytical framework examining three distinct practices that use similar methods. Here, we present demographic and outcome data from 235 patients. Our findings suggest that KAP is an effective method for decreasing depression and anxiety in a private practice setting, especially for older patients and those with severe symptom burden.
AbstractList Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several years, ketamine has come into psychiatric use as an intervention for treatment resistant depression (TRD), administered intravenously without a psychotherapeutic component. In these settings, ketamine's psychedelic effects are viewed as undesirable "side effects." In contrast, we believe ketamine can benefit patients with a wide variety of diagnoses when administered with psychotherapy and using its psychedelic properties without need for intravenous (IV) access. Its proven safety over decades of use makes it ideal for office and supervised at-home use. The unique experience that ketamine facilitates with its biological, experiential, and psychological impacts has been tailored to optimize office-based treatment evolving into a method that we call Ketamine Assisted Psychotherapy (KAP). This article is the first to explore KAP within an analytical framework examining three distinct practices that use similar methods. Here, we present demographic and outcome data from 235 patients. Our findings suggest that KAP is an effective method for decreasing depression and anxiety in a private practice setting, especially for older patients and those with severe symptom burden.
Author Andries, Julane
Strauss, Nicole
Huidekoper, Angela
Turnipseed, Andrea
Wolfson, Phil
Monnette, Celeste
Dore, Jennifer
Ascani, German
Dwyer, Shannon
Turnipseed, Brent
Author_xml – sequence: 1
  givenname: Jennifer
  surname: Dore
  fullname: Dore, Jennifer
  organization: Helios Psychiatry
– sequence: 2
  givenname: Brent
  surname: Turnipseed
  fullname: Turnipseed, Brent
  organization: Roots Behavioral Health
– sequence: 3
  givenname: Shannon
  surname: Dwyer
  fullname: Dwyer, Shannon
  organization: Helios Psychiatry
– sequence: 4
  givenname: Andrea
  surname: Turnipseed
  fullname: Turnipseed, Andrea
  organization: Roots Behavioral Health
– sequence: 5
  givenname: Julane
  surname: Andries
  fullname: Andries, Julane
  organization: Center for Transformational Psychotherapy
– sequence: 6
  givenname: German
  surname: Ascani
  fullname: Ascani, German
  organization: Center for Transformational Psychotherapy
– sequence: 7
  givenname: Celeste
  surname: Monnette
  fullname: Monnette, Celeste
  organization: Center for Transformational Psychotherapy
– sequence: 8
  givenname: Angela
  surname: Huidekoper
  fullname: Huidekoper, Angela
  organization: Ketamine Research Foundation
– sequence: 9
  givenname: Nicole
  surname: Strauss
  fullname: Strauss, Nicole
  organization: Ketamine Research Foundation
– sequence: 10
  givenname: Phil
  surname: Wolfson
  fullname: Wolfson, Phil
  email: ketamine.research@gmail.com
  organization: Ketamine Research Foundation
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30917760$$D View this record in MEDLINE/PubMed
BookMark eNp9kctqGzEUQEVJaZy0n9Ai6CaFjqvHaCR1VeP0RQzxIl0LWdJ4FGYkR5IJ_pV-bWewE2gXXWlxz71HcC7AWYjBAfAWozlGAn1ChEuMOJkThOUcM8EZa16AGcFMVpJzfgZmE1NN0Dm4yPkeIdSQpnkFzimSmPMGzcDvG1f04IODi5x9Ls7CdT6YLpbOJb07wKubxfrDZ7jWxbtQ4LUb4nYcdN7kj3DZ--CN7uG1LhrqYOHtvpg4uAx9gHddcg6udNo6uE7aFG_GwcKOusmUfNjCZ_2jL93f6tfgZav77N6c3kvw69vXu-WPanX7_edysapMXeNSUWcxddSKBjFe27Y2DGPLBBaCUCQYMZZtDG2Q2FiCiGbCtZJtBGpFKy1j9BJcHe_uUnzYu1zU4LNxfa-Di_usCJYSC86pHNH3_6D3cZ_C-DtFCCWE17RGI8WOlEkx5-RatUt-0OmgMFJTPPUUT03x1CneuPfudH2_GZx93nqqNQJfjoAPbUyDfoypt6roQx9Tm3QwPiv6f8cfB9erDA
CitedBy_id crossref_primary_10_1080_02791072_2021_1957183
crossref_primary_10_17744_mehc_42_4_03
crossref_primary_10_31640_2706_8803_2022__3_4__04
crossref_primary_10_1080_17512433_2021_1933434
crossref_primary_10_3389_fpsyt_2024_1398859
crossref_primary_10_1124_pr_119_018697
crossref_primary_10_3390_brainsci12030382
crossref_primary_10_3389_fpsyt_2023_1197697
crossref_primary_10_3389_fphar_2022_916641
crossref_primary_10_1007_s10615_019_00743_x
crossref_primary_10_1016_j_heliyon_2023_e15883
crossref_primary_10_1111_jmwh_13371
crossref_primary_10_3928_00485713_20220810_04
crossref_primary_10_1192_bjo_2021_1061
crossref_primary_10_1080_17512433_2020_1772054
crossref_primary_10_1186_s40345_022_00265_5
crossref_primary_10_2217_cer_2022_0149
crossref_primary_10_1172_JCI180217
crossref_primary_10_1192_bjp_2022_58
crossref_primary_10_2147_JPR_S360733
crossref_primary_10_3389_fpsyt_2024_1209419
crossref_primary_10_1080_28376811_2024_2371792
crossref_primary_10_1089_psymed_2023_0002
crossref_primary_10_1523_JNEUROSCI_1659_20_2020
crossref_primary_10_3389_fnhum_2023_1200393
crossref_primary_10_1017_S1478951522001304
crossref_primary_10_1007_s00213_023_06388_6
crossref_primary_10_1080_14740338_2022_2069749
crossref_primary_10_1186_s40337_022_00588_9
crossref_primary_10_1080_18387357_2023_2235030
crossref_primary_10_3389_fpsyt_2022_865466
crossref_primary_10_1038_s41467_020_20190_4
crossref_primary_10_3389_fpsyt_2021_710338
crossref_primary_10_3389_fpsyt_2021_695335
crossref_primary_10_1016_j_encep_2021_08_011
crossref_primary_10_3389_fpsyt_2023_1268832
crossref_primary_10_1177_0269881121997099
crossref_primary_10_1080_02791072_2019_1606472
crossref_primary_10_1038_s44220_023_00140_x
crossref_primary_10_1080_02791072_2023_2253798
crossref_primary_10_1089_psymed_2023_0071
crossref_primary_10_1093_ijnp_pyaa018
crossref_primary_10_1227_neu_0000000000002275
crossref_primary_10_1016_j_jcbs_2019_11_001
crossref_primary_10_1016_j_jad_2022_06_036
crossref_primary_10_1017_S147895152300069X
crossref_primary_10_1177_1534650121990894
crossref_primary_10_1016_j_jad_2021_12_097
crossref_primary_10_1007_s00213_023_06324_8
crossref_primary_10_1080_02791072_2024_2341811
crossref_primary_10_3389_fpsyt_2023_1246891
crossref_primary_10_3389_fpsyg_2022_868103
crossref_primary_10_1038_s41386_023_01666_5
crossref_primary_10_3389_fpsyt_2021_803279
crossref_primary_10_22374_jmhan_v4i1_40
crossref_primary_10_1016_j_jpsychires_2022_04_037
crossref_primary_10_1016_j_tips_2021_08_003
crossref_primary_10_3389_fpsyt_2022_992624
crossref_primary_10_3390_psych4010012
crossref_primary_10_1080_02791072_2022_2154722
crossref_primary_10_3389_fpsyt_2022_948115
crossref_primary_10_1192_bjo_2023_53
crossref_primary_10_1177_0269881121998321
crossref_primary_10_1097_HRP_0000000000000330
crossref_primary_10_1007_s00213_022_06083_y
crossref_primary_10_1186_s12888_022_04268_5
crossref_primary_10_1080_02791072_2023_2248989
crossref_primary_10_1016_j_jad_2022_09_083
crossref_primary_10_1080_02791072_2022_2101903
crossref_primary_10_1007_s00213_021_05825_8
crossref_primary_10_1097_YIC_0000000000000363
crossref_primary_10_1177_20451253231171512
crossref_primary_10_31392_NPU_nc_series15_2023_10_170__32
crossref_primary_10_1080_02791072_2021_1912863
crossref_primary_10_3389_fnins_2023_1197409
crossref_primary_10_1007_s00213_021_06027_y
crossref_primary_10_4102_sajpsychiatry_v30i0_2176
crossref_primary_10_3389_fpsyt_2022_1020214
crossref_primary_10_1080_02791072_2023_2186285
crossref_primary_10_1176_appi_ajp_2019_19010035
crossref_primary_10_1007_s43440_021_00232_4
crossref_primary_10_1007_s44192_022_00012_3
crossref_primary_10_3389_fpsyt_2023_1141988
crossref_primary_10_1089_psymed_2023_0021
crossref_primary_10_1089_cap_2021_0078
crossref_primary_10_1093_ijnp_pyae017
crossref_primary_10_1177_02698811221140011
crossref_primary_10_1176_appi_focus_19104
crossref_primary_10_3389_fpsyt_2023_1214018
crossref_primary_10_1016_j_encep_2022_08_011
crossref_primary_10_1016_j_jad_2023_04_019
crossref_primary_10_1016_j_neuropharm_2022_109375
crossref_primary_10_1055_a_1981_3152
crossref_primary_10_1521_pdps_2023_51_4_467
crossref_primary_10_1556_2054_2022_00211
crossref_primary_10_1016_j_jad_2024_05_131
crossref_primary_10_1007_s11469_023_01160_5
crossref_primary_10_1016_j_neubiorev_2023_105410
crossref_primary_10_3390_bs11090118
crossref_primary_10_1007_s00278_024_00710_z
crossref_primary_10_3389_fpsyt_2021_764112
crossref_primary_10_1093_ijnp_pyae024
crossref_primary_10_1177_23982128211007772
crossref_primary_10_3389_fpsyg_2021_645246
crossref_primary_10_1556_2054_2021_00179
crossref_primary_10_1016_j_euroneuro_2022_09_004
crossref_primary_10_1177_02698811221084055
crossref_primary_10_1007_s40263_022_00897_2
crossref_primary_10_1016_j_jad_2022_07_030
Cites_doi 10.1016/S0033-3182(73)71306-2
10.1001/archpsyc.1994.03950030035004
10.4103/0253-7176.127258
10.1007/s00213-017-4779-2
10.1111/nyas.12223
10.1080/02791072.1997.10400185
10.1017/S0033291714001603
10.24972/ijts
10.1177/0269881118754710
10.1007/s00213-011-2358-5
10.1007/978-3-319-42925-0
10.1016/j.jad.2014.02.017
10.1016/j.biopsych.2009.08.038
10.3389/fnhum.2016.00269.eCollection2016
10.1017/S1461145713000485
10.3389/fpsyg.2018.01475
10.1016/S0006-3223(99)00230-9
10.1176/appi.ajp.2012.12020219
10.1016/S2215-0366(15)00576-3
10.1038/sj.npp.1300994
10.1176/appi.ajp.2018.18020138
ContentType Journal Article
Copyright 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019
2019 The Author(s). Published with license by Taylor & Francis Group, LLC.
Copyright_xml – notice: 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. 2019
– notice: 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.
DBID 0YH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K7.
K9.
NAPCQ
7X8
DOI 10.1080/02791072.2019.1587556
DatabaseName Taylor & Francis (Open Access)
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Criminal Justice (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
ProQuest Criminal Justice (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Social Welfare & Social Work
Psychology
Pharmacy, Therapeutics, & Pharmacology
EISSN 2159-9777
EndPage 198
ExternalDocumentID 10_1080_02791072_2019_1587556
30917760
1587556
Genre Articles
Multicenter Study
Journal Article
GrantInformation_xml – fundername: None of the authors of this paper have a financial interest or benefit arising from the direct applications of this research
GroupedDBID ---
-DZ
-~X
.7I
.QK
07V
0BK
0R~
0YH
29L
36B
4.4
53G
5GY
5RE
6PF
7RV
85S
8R4
8R5
AAGZJ
AAJNR
AALUX
AAMIU
AAPUL
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABIVO
ABLCE
ABPEM
ABPTK
ABTAI
ABUPF
ACENM
ACGFO
ACGFS
ACGOD
ACHQT
ACLSK
ACNCT
ACTOA
ACVOX
ADCVX
ADFCX
AECIN
AEKEX
AEOZL
AFOLD
AFWLO
AGDLA
AGFJD
AGMYJ
AGRBW
AGYJP
AHMBA
AIJEM
AIRBT
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
ARJSQ
AVBZW
BLEHA
BMOTO
BOHLJ
CCCUG
CQ1
DGFLZ
DKSSO
EAP
EAS
EBS
EJD
EMB
EMK
EMOBN
ESX
E~B
E~C
F5P
F8P
FUNRP
G-F
GTTXZ
H13
HF~
HZ~
IPNFZ
J.O
KDLKA
KUULJ
KYCEM
LJTGL
M4Z
NA5
NZ~
O9-
P2P
Q2X
RNANH
RVRKI
RWL
RXW
S-F
STATR
SV3
TAE
TFL
TFW
TN5
TNTFI
TUS
UC6
UEQFS
UT5
UT9
V1K
WH7
YCJ
ZCA
~01
~S~
.GJ
0-V
0VX
3V.
7X7
88E
88I
8AF
8AO
8FI
8FJ
8FW
AAIAR
AAORF
ABFIM
ABJNI
ABLIJ
ABUWG
ABWCV
ABXYU
ABZEW
ACBNA
ACIEZ
ACKZS
ADBBV
ADFOM
ADFZZ
AEIIZ
AFFNX
AFKRA
AFLEI
AJSLH
AJVHN
ALIPV
ALSLI
ALYBC
AMATQ
ARALO
AZQEC
BENPR
BGRYB
BKEYQ
BPHCQ
BRMBE
BVXVI
C04
CCPQU
CGR
CUY
CVF
CYYVM
CZDIS
DMVAR
DRXRE
DWQXO
DWTOO
ECM
EIF
EX3
FYUFA
G8K
GNUQQ
HCIFZ
HMCUK
H~9
JENTW
M0O
M1P
M2M
M2P
M2Q
NAPCQ
NPM
NUSFT
OHT
PQQKQ
PROAC
PSQYO
PSYQQ
QQXMO
RIG
S0X
TBQAZ
TDBHL
TERGH
TUROJ
UKHRP
WOW
ZCG
ZGI
ZXP
AAYXX
CITATION
K7.
K9.
7X8
ID FETCH-LOGICAL-c441t-3ed13e3d860574df4c511d58188230852cd5bc3608bd202a58ef95b80f8f9d553
IEDL.DBID TFW
ISSN 0279-1072
IngestDate Fri Oct 25 22:06:55 EDT 2024
Mon Nov 04 11:26:53 EST 2024
Fri Aug 23 04:03:39 EDT 2024
Wed Oct 16 00:45:05 EDT 2024
Tue Jun 13 19:51:39 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords PTSD
psychedelics
Depression
psychotherapy
ketamine
psychedelic psychotherapy
Language English
License open-access: http://creativecommons.org/licenses/by-nc-nd/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-3ed13e3d860574df4c511d58188230852cd5bc3608bd202a58ef95b80f8f9d553
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/02791072.2019.1587556
PMID 30917760
PQID 2232274340
PQPubID 41415
PageCount 10
ParticipantIDs informaworld_taylorfrancis_310_1080_02791072_2019_1587556
pubmed_primary_30917760
crossref_primary_10_1080_02791072_2019_1587556
proquest_miscellaneous_2199187739
proquest_journals_2232274340
PublicationCentury 2000
PublicationDate 2019 Apr-Jun
PublicationDateYYYYMMDD 2019-04-01
PublicationDate_xml – month: 04
  year: 2019
  text: 2019 Apr-Jun
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
PublicationTitle Journal of psychoactive drugs
PublicationTitleAlternate J Psychoactive Drugs
PublicationYear 2019
Publisher Taylor & Francis
Haight Ashbury Publications
Publisher_xml – name: Taylor & Francis
– name: Haight Ashbury Publications
References Early T. (CIT0006) 2016
Brown D. A. (CIT0001) 2016
Wieber J. (CIT0034) 1975; 24
Weber F. (CIT0033) 2004; 14
Hyde S. J. (CIT0010) 2015
Fontana A. (CIT0008) 1974; 20
CIT0014
CIT0013
CIT0035
CIT0038
CIT0015
CIT0018
Jansen K. (CIT0012) 2004
CIT0017
CIT0019
Yensen R. (CIT0037) 2016
CIT0021
Krystal J. H. (CIT0016) 2007; 137
CIT0020
CIT0023
CIT0022
Ryan W. (CIT0028) 2016
Wolfson P. (CIT0036) 2016
Van Der Kolk B. (CIT0031) 2014
Jaitly V. (CIT0011) 2013; 1
CIT0003
CIT0025
CIT0002
CIT0024
Schwartz R. (CIT0029) 1995
CIT0005
CIT0027
CIT0004
CIT0026
CIT0007
CIT0009
References_xml – ident: CIT0013
  doi: 10.1016/S0033-3182(73)71306-2
– ident: CIT0017
  doi: 10.1001/archpsyc.1994.03950030035004
– ident: CIT0003
  doi: 10.4103/0253-7176.127258
– ident: CIT0007
  doi: 10.1007/s00213-017-4779-2
– ident: CIT0038
  doi: 10.1111/nyas.12223
– ident: CIT0015
  doi: 10.1080/02791072.1997.10400185
– volume-title: Ketamine: Dreams and realities
  year: 2004
  ident: CIT0012
  contributor:
    fullname: Jansen K.
– ident: CIT0022
  doi: 10.1017/S0033291714001603
– volume-title: Internal family systems therapy
  year: 1995
  ident: CIT0029
  contributor:
    fullname: Schwartz R.
– volume: 20
  start-page: 32
  year: 1974
  ident: CIT0008
  publication-title: Acta psiquiatrica y psicologica de America latina
  contributor:
    fullname: Fontana A.
– ident: CIT0014
  doi: 10.24972/ijts
– volume-title: The ketamine papers
  year: 2016
  ident: CIT0036
  contributor:
    fullname: Wolfson P.
– volume-title: The body keeps the score
  year: 2014
  ident: CIT0031
  contributor:
    fullname: Van Der Kolk B.
– ident: CIT0002
  doi: 10.1177/0269881118754710
– volume: 137
  start-page: 215
  issue: 15
  year: 2007
  ident: CIT0016
  publication-title: Swiss Medical Weekly
  contributor:
    fullname: Krystal J. H.
– ident: CIT0009
  doi: 10.1007/s00213-011-2358-5
– ident: CIT0021
  doi: 10.1007/978-3-319-42925-0
– start-page: 305
  volume-title: The ketamine papers: Science,therapy and transformation
  year: 2016
  ident: CIT0006
  contributor:
    fullname: Early T.
– ident: CIT0020
  doi: 10.1016/j.jad.2014.02.017
– ident: CIT0027
  doi: 10.1016/j.biopsych.2009.08.038
– volume: 14
  start-page: 983
  issue: 12
  year: 2004
  ident: CIT0033
  publication-title: Paediatr†anaesth
  contributor:
    fullname: Weber F.
– ident: CIT0025
  doi: 10.3389/fnhum.2016.00269.eCollection2016
– start-page: 69
  volume-title: The ketamine papers
  year: 2016
  ident: CIT0037
  contributor:
    fullname: Yensen R.
– ident: CIT0019
  doi: 10.1017/S1461145713000485
– ident: CIT0023
  doi: 10.3389/fpsyg.2018.01475
– volume-title: Ketamine and depression
  year: 2015
  ident: CIT0010
  contributor:
    fullname: Hyde S. J.
– volume-title: Attachment disorder in adults
  year: 2016
  ident: CIT0001
  contributor:
    fullname: Brown D. A.
– ident: CIT0026
  doi: 10.1016/S0006-3223(99)00230-9
– start-page: 199
  volume-title: The ketamine papers
  year: 2016
  ident: CIT0028
  contributor:
    fullname: Ryan W.
– ident: CIT0005
  doi: 10.1176/appi.ajp.2012.12020219
– ident: CIT0024
  doi: 10.1016/S2215-0366(15)00576-3
– volume: 1
  issue: 2013
  year: 2013
  ident: CIT0011
  publication-title: Journal of Observational Pain Medicine
  contributor:
    fullname: Jaitly V.
– ident: CIT0018
  doi: 10.1038/sj.npp.1300994
– ident: CIT0004
  doi: 10.1016/j.biopsych.2009.08.038
– volume: 24
  start-page: 260
  issue: 6
  year: 1975
  ident: CIT0034
  publication-title: Anaesthesist
  contributor:
    fullname: Wieber J.
– ident: CIT0035
  doi: 10.1176/appi.ajp.2018.18020138
SSID ssj0006266
Score 2.562485
Snippet Currently, ketamine is the only legal psychedelic medicine available to mental health providers for the treatment of emotional suffering. Over the past several...
SourceID proquest
crossref
pubmed
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 189
SubjectTerms Adult
Anxiety - therapy
Clinical outcomes
Combined Modality Therapy
Demographics
Depression
Depression - therapy
Drug therapy
Female
Hallucinogens - administration & dosage
Humans
Ketamine
Ketamine - administration & dosage
Male
Mental depression
psychedelic psychotherapy
psychedelics
Psychotherapy
Psychotherapy - methods
Psychotropic drugs
PTSD
Retrospective Studies
Title Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
URI https://www.tandfonline.com/doi/abs/10.1080/02791072.2019.1587556
https://www.ncbi.nlm.nih.gov/pubmed/30917760
https://www.proquest.com/docview/2232274340
https://search.proquest.com/docview/2199187739
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELZaeuHSB32wdIumUoVaiUBeXju9rdhdIdHSSN2K3iIntiVUyKJN9rB_pb-2M3ES2APqAY5J7Hgsf7Y_2zOfGfukSFMk1tLz40iRqLb08gL7VY7YMaHASVBToPDpT3H-W06mJJMz7mJhyK2S1tDWCUU0YzV1bpVXnUfcMa6kcJITFEYVJEcBR8rNSXSbNLcR0fPZRT8WI11vTisxh0dZuhie-_6yMTttaJfez0CbmWj24hHq8JI9b2kojB1uXrEnptxhB6nTsV4fwvw2LKs6hANIbxWu1ztsux828WHoInzhwlxZtTSYuHuxWP55zf6emVpdo4GASCBMaUjvRH6t4fPZOP3yFVIn8AoTc-1UtJuSW9nSK5ioWgHWFn6saqypqeCyRCuXxsA3cmaHtA33qqDTA25EFqEvnnacN4t-w37NpvOTU6-9EMIrkLXVXmQ0bdpqiWswEWsbF0gXNUfOQceFkoeF5oi0kS9zHfqh4tLYhOfSt9ImmvPoLdsqF6XZZZAUATdBZEMjbBzIPA-UKXKlRiPka0hjB-yoA0J243Q_sqCTU23bLqO2y9q2G7DkLlyyutlwse52lCz6T95hh62sHUKqDHlbGCK_i_0B-9h_xs5PJzqqNIsVpiHHNSlElAzYO4fJ3toImaAQI3_vAYa9Z9v06DyVhmyrXq7MB_a00qt99mx8Mj3_vt_0t392ISU3
link.rule.ids 315,782,786,1455,1509,27935,27936,58024,59737,59871,60526,60660
linkProvider Taylor & Francis
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFD5i2wN74TJuhQIHCU0gLSM3Jw5v1dqpqF2JRBG8WU7sSIgtRU360L_Cr-U4TrL1YeIBHpPYsS1_Pv5sn_MZ4K00miKh4o4bBtKIanMny2lcZYQd7cc0CSoTKDz9Ei--8_HEyOT0sTDGrdKsoQsrFNHYajO4zWZ05xL3gZZSNMvFJo7KS049RpybRXtwwGgBTYPzYHQ2WVz09pgoe3NiSZkck6uL47ntRzsz1I5-6e0stJmNzu__j3Y8gHstF8WRBc9DuKPLIzhOrZj19gSX17FZ1QkeY3otc709gsPedtLD0Ib54jd9Wci1psTdi9X65yP4PdO1vKIaIsHBAEtheiP8a4vvZqP0_UdMrcorjvWVldJuSm61Sy9xLGuJ1Fz8vKmpqbrCHyXVcq01zo1HO6ZtzFeFnShwo7SIffFm23m36Mfw9XyyPJs67a0QTk7UrXYCrczOreK0EItDVYQ5cUbFiHiYM0PO_Fwxglvk8kz5ri8Z10XCMu4WvEgUY8ET2C9XpX4GmOQe015Q-DouQo9nmSd1nkkZRUTaiMsO4LRDgvhlxT-E12mqtn0nTN-Jtu8GkNzEi6ibXZfCXpEigr_kHXbgEq0dqQSRN98nkhe6A3jTfyYLYI51ZKlXG0pjvNd4HAfJAJ5aUPa1DYgOxnHkPv-Hir2Gu9PlxVzMPy1mL-DQfLKuS0PYr9cb_RL2KrV51Q67P9vaKMA
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB7RIqFeeJTXwgKDhCqQmpKXE4fbiu2qaKsSiUXlZjmxLSHabLXJHvav8GsZx0naPVQc4JjEjm35s-ezPfMZ4J20miKx4p4fR9KKanOvKGlcFYQdHaZkBJUNFD75lp794NNjK5Mz6WNhrFulXUMbJxTRztV2cF8p03vEfaSVFBm51IZRBdlRwIhys2QH7jJOBocgvZidD5Mx8fX2uJKyeDZPH8Rz22-2zNOWeOntFLQ1RbMH_6ERD-F-x0Nx4oDzCO7oah8OcidkvTnExXVcVn2IB5hfS1xv9mFvmDfpYexCfPFcXxi50pS4f7Fc_XoMv-e6kZdUQSQoWFApzG-Efm3w_XySf_iEuVN4xam-dDLabcmdbukFTmUjkVqLX9cNtVTX-LOiWq60xlPrzY55F-9VYy8I3Kos4lC83XLeLvoJfJ8dLz6feN2NEF5JtK3xIq3srq3itAhLY2XikviiYkQ67HkhZ2GpGEEt8XmhQj-UjGuTsYL7hptMMRY9hd1qWenngFkZMB1EJtSpiQNeFIHUZSFlkhBhIx47gqMeCOLKCX-IoNdT7fpO2L4TXd-NILsJF9G0Oy7GXY8ior_kHffYEt0cUgsibmFIBC_2R_B2-Eyj3x7pyEov15TGeq7xNI2yETxzmBxqGxEVTNPEf_EPFXsD9_LpTJx-OZu_hD37xXktjWG3Wa31K9ip1fp1O-T-AOV0Jns
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ketamine+Assisted+Psychotherapy+%28KAP%29%3A+Patient+Demographics%2C+Clinical+Data+and+Outcomes+in+Three+Large+Practices+Administering+Ketamine+with+Psychotherapy&rft.jtitle=Journal+of+psychoactive+drugs&rft.au=Dore%2C+Jennifer&rft.au=Turnipseed%2C+Brent&rft.au=Dwyer%2C+Shannon&rft.au=Turnipseed%2C+Andrea&rft.date=2019-04-01&rft.pub=Taylor+%26+Francis&rft.issn=0279-1072&rft.eissn=2159-9777&rft.volume=51&rft.issue=2&rft.spage=189&rft.epage=198&rft_id=info:doi/10.1080%2F02791072.2019.1587556&rft.externalDBID=0YH&rft.externalDocID=1587556
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0279-1072&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0279-1072&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0279-1072&client=summon